Low-intensity shockwave therapy for erectile dysfunction in kidney transplant recipients. A prospective, randomized, double blinded, sham-controlled study with evaluation by penile Doppler ultrasonography

Imagem de Miniatura
Arquivos
art_YAMACAKE_Lowintensity_shockwave_therapy_for_erectile_dysfunction_in_kidney_2019.PDF (904.95 KB)
Citações na Scopus
39
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Autores
Citação
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, v.31, n.3, p.195-203, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To study the efficacy of Low intensity Extracorporeal Shockwave Therapy (Li- ESWT) for the treatment of erectile dysfunction (ED) in kidney transplanted men. Methods: Twenty men (mean age = 53.7 years) were selected. This was a double-blinded, prospective, randomized, sham-controlled trial. The ESWT protocol was based in a 2 treatment sessions per week for 3 weeks. The sham treatment was performed using the same device replacing the effective probe for one that emits zero energy. Baseline and follow-up assessment was performed with International Index of Erectile Function Questionnaire (IIEF) score and Erection Hardness Score (EHS) after 1, 4 and 12 months. Penile Doppler was performed before and after treatment. Results: A total of 20 patients were recruited, 10 patients in each group. Baseline scores were similar. The mean EHS in after 1 month were 2.5 +/- 0.85 (Li-EWST) and 2.4 +/- 0.7 (Sham therapy), p = 0.724 . After 4 months it was 2.4 +/- 0.7 and 2.6 +/- 0.84, p = 0,0004 (between the moments) . The baseline IIEF score was 14.9 +/- 3(Sham Theraphy) and 10.9 +/- 5.1 (Li-EWST). The mean IIEF score after 1 month was 15.6 +/- 6.1 (Li-EWST) and 16.6 +/- 5.4 (Sham therapy). The mean IIEF score after 4 months was 17.2 +/- 5.7 (Li-EWST) and 16.5 +/- 5 (Sham therapy), p < 0.0001 (between the moments). IIEF score improvement was higher than 5 in 70% (ranged from 0-10) and in 10% (ranged from 1-14) in Li-ESWT and Sham groups, respectively. The mean change in IIEF score after 12 months was 4.8 in Li-ESWT group .Penile Doppler parameters were similar between groups and did not present improvements. Conclusions: Li-ESWT is a treatment with clinical efficacy. Despite evidences suggesting neoagiogenesis, our short protocol had no impact in penile Doppler parameters.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/32389
Referências
  1. Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623
  2. Althof SE, 2002, UROLOGY, V59, P803, DOI 10.1016/S0090-4295(02)01606-0
  3. Aversa A, 2007, EXPERT OPIN DRUG MET, V3, P451, DOI 10.1517/17425255.3.3.451
  4. Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0
  5. Eardley I, 2006, NAT CLIN PRACT UROL, V3, P72, DOI 10.1038/ncpuro0411
  6. Eardley I, 2010, J SEX MED, V7, P524, DOI 10.1111/j.1743-6109.2009.01627.x
  7. El-Assmy A, 2004, SCAND J UROL NEPHROL, V38, P511, DOI 10.1080/00365590410015849
  8. FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1
  9. Gonzales AI, 2013, ARQ BRAS CARDIOL, V101, P176, DOI 10.5935/abc.20130141
  10. Gotte G, 2002, FEBS LETT, V520, P153, DOI 10.1016/S0014-5793(02)02807-7
  11. Gruenwald I, 2012, J SEX MED, V9, P259, DOI 10.1111/j.1743-6109.2011.02498.x
  12. Jensen J, 1999, AM J HYPERTENS, V12, P271, DOI 10.1016/S0895-7061(98)00225-8
  13. Kalyvianakis D, 2018, J SEX MED, V15, P334, DOI 10.1016/j.jsxm.2018.01.003
  14. Kovanecz I, 2009, BJU INT, V103, P1396, DOI 10.1111/j.1464-410X.2008.08251.x
  15. Liu J, 2013, INT J MOL SCI, V14, P10661, DOI 10.3390/ijms140510661
  16. Lu ZH, 2017, EUR UROL, V71, P223, DOI 10.1016/j.eururo.2016.05.050
  17. Malavaud B, 2000, TRANSPLANTATION, V69, P2121, DOI 10.1097/00007890-200005270-00027
  18. Mulhall JP, 2007, J SEX MED, V4, P1626, DOI 10.1111/j.1743-6109.2007.00600.x
  19. Olsen AB, 2015, SCAND J UROL, V49, P329, DOI 10.3109/21681805.2014.984326
  20. Petschnik AE, 2010, EXPERT OPIN BIOL TH, V10, P853, DOI 10.1517/14712591003769832
  21. Porst H, 2008, J SEX MED, V5, P2160, DOI 10.1111/j.1743-6109.2008.00935.x
  22. Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0
  23. Toorians AWFT, 1997, NEPHROL DIAL TRANSPL, V12, P2654, DOI 10.1093/ndt/12.12.2654
  24. Vardi Y, 2012, J UROLOGY, V187, P1769, DOI 10.1016/j.juro.2011.12.117
  25. Vardi Y, 2010, EUR UROL, V58, P243, DOI 10.1016/j.eururo.2010.04.004
  26. Vardi Y, 2009, J UROLOGY, V182, P2850, DOI 10.1016/j.juro.2009.08.025
  27. Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9
  28. 2017, NAT REV UROL, V14, P593, DOI 10.1038/NRUROL.2017.119

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/44
Artigos e Materiais de Revistas Científicas - LIM/55